Page last updated: 2024-10-31

metyrapone and Autonomic Failure, Progressive

metyrapone has been researched along with Autonomic Failure, Progressive in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research Excerpts

ExcerptRelevanceReference
" The patients showed a poor cortisol response to the stress of insulin induced hypoglycemia along with a normal ACTH and urinary 17-OHCS response to metyrapone and a normal cortisol circadian rhythm."3.66Pituitary-adrenocortical system in patients with Shy-Drager syndrome. ( Aoyagi, K; Baba, T; Kitaoka, M; Mastunaga, M; Murabayashi, S; Sasaki, K; Takebe, K, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sasaki, K1
Aoyagi, K1
Murabayashi, S1
Baba, T1
Kitaoka, M1
Mastunaga, M1
Takebe, K1

Other Studies

1 other study available for metyrapone and Autonomic Failure, Progressive

ArticleYear
Pituitary-adrenocortical system in patients with Shy-Drager syndrome.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1983, Volume: 15, Issue:3

    Topics: Adrenocorticotropic Hormone; Autonomic Nervous System Diseases; Circadian Rhythm; Feedback; Female;

1983